Skip to main content

Table 1 Characteristics of HIV-exposed infants and their HIV-1 infected mothers enrolled for care at a rural HIV clinic in Kenya (N = 634)

From: Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya—a cohort study

  

Standard Care

Active follow up

Overall Care

Infants Characteristics

 

N = 537 [%]

N = 97 [%]

N = 634 [%]

Gender

Male

224 [41.7]

44 [45.4]

268 [42.3]

Female

313 [58.3]

53 [54.6]

366 [57.7]

Age at intake (months)

Median (IQR)

0.9 (0.3–3.5)

0.6 (0.3–1.5)

0.8 (0.3–3.0)

Age group at enrollment (months)

0–3

394 [73.4]

81 [83.5]

475 [74.9]

3–6

52 [9.7]

13 [13.4]

65 [10.3]

>6

91 [17.9]

3 [3.1]

94 [14.8]

Hospital distance (kilometers)

Median (IQR)

7.4 (2.2–13.4)

7.8 (2.2–17.7)

7.4 (2.2–13.4)

Hospital distance categories (kilometers)

0–5

206 [38.4]

40 [41.2]

246 [38.8]

5–10

136 [25.3]

22 [22.7]

158 [24.9]

>10

152 [28.3]

34 [35.1]

186 [29.3]

Missing

43 [8.0]

1 [1.0]

44 [6.9]

Mothers Characteristics (at infant’s birth)

 

N = 364 [%]

N = 94 [%]

N = 458 [%]

Age (years)

Median (IQR)

28.1 (23.3–33.5)

28.9 (24.8–34.9)

28.4 (23.7–33.8)

Age group (years)

<25

120 [33.0]

24 [25.5]

144 [31.4]

25–35

177 [48.6]

47 [50.0]

224 [48.9]

>35

67 [18.4]

23 [24.5]

90 [19.7]

Education status

No education

133 [36.5]

30 [31.9]

163 [35.6]

Primary

165 [45.3]

41 [43.6]

206 [45.0]

>Secondary

39 [10.7]

11 [11.7]

50 [10.9]

Missing

27 [7.4]

12 [12.8]

39 [8.5]

BMI

Median (IQR)

21.0 (19.2–23.4)

21.4 (19.1–23.2)

21.0 (19.2–23.3)

BMI categories

<18.5

56 [15.4]

15 [16.0]

71 [15.5]

>18.5

296 [81.3]

77 [81.9]

373 [81.4]

Missing

12 [3.3]

2 [2.1]

14 [3.1]

CD4 count

Median (IQR)

409 (264–549)

420 (300–640)

410 (279–571)

CD4 count categories

<350

85 [23.4]

25 [26.6]

110 [24.0]

>350

121 [33.2]

40 [42.6]

161 (35.2)

Missing

158 [43.4]

29 [30.9]

187 (40.8)

Duration on HAART (months)

Median (IQR)

20.6 (2.9–36.9)

28.1 (7.1–44.6)

24.9 (3.4–39.3)

Duration on HAART categories (months)

Not on HAARTa

229 [62.9]

50 [53.2]

279 [60.9]

0–24

71 [19.5]

17 [18.1]

88 [19.2]

>24

64 [17.6]

27 [28.7]

91 [19.8]

  1. Infants missing mothers data (n = 176 [28 %]); BMI: body mass index, HAART: Highly active antiretroviral therapy, IQR interquartile range
  2. amothers not on HAART received prophylactic antiretroviral therapy azidothymidine (AZT) during, through and after delivery, as per the Kenyan guidelines at the time of the study, ref [19] if they had attended antenatal clinic